Der er utilstrækkelig dokumentation for risikoen for selvmordsrelateret adfærd ved behandlingsnaive patienter, men nøje overvågning kan være berettiget.
As improvement may not occur during the first few weeks or more of treatment, patients should be closely monitored until such improvement occurs.